Joined Today: 3

BCLI BrainStorm Cell Therapeutics, Stock Message Board

All Messages

BCLI Message Board Home | Join The BCLI Group |

#8: BCLI News BrainStorm Cell Therapeutics Retains AGORACOM Investor Relations; AGORACOM to Provide Fully Integrated IR Services Including Access to AOL Small Cap Centre, Yahoo! Finance Canada and 4.3 Million Blackberry Devices
Stock News Bot	July 27, 2006 05:34:00 AM
NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--July 27, 2006--BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), the developer of NurOwn(TM) bone marrow-derived-stem cell therapeutic products for the... view message ignore post recommend post

#7: BCLI News BrainStorm Cell Therapeutics Responds to the Veto of the Stem Cell Research Enhancement Act (HR-810)
Stock News Bot	July 20, 2006 11:19:00 AM
NEW YORK--(BUSINESS WIRE)--July 20, 2006-- Adult Stem Cell Research Shows Extremely Promising Results and Offers a Promising Alternative to the Controversial Embryonic Stem Cell Approach... view message ignore post recommend post

#6: BCLI News BrainStorm Advances Its International Patent Application (PCT) for Stem Cell Procedure with Potential for Treating Parkinson's and Other Neurodegenerative Diseases
Stock News Bot	July 11, 2006 05:30:00 AM
NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--July 11, 2006--BrainStorm Cell Therapeutics (OTCBB:BCLI) announced today that it has advanced its patent application from a provisional to an... view message ignore post recommend post

#5: BCLI News BrainStorm Makes Progress Towards Human Stem Cell Therapy for Parkinson's -- Animal Model Shows Long-Term Benefit
Stock News Bot	December 13, 2005 02:30:00 AM
NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Dec. 13, 2005--BrainStorm Cell Therapeutics (OTCBB:BCLI), the developer of NurOwn(TM) bone marrow derived stem cell therapeutic products for the... view message ignore post recommend post

#4: BCLI News California Legislators Visit BrainStorm Research Facility
Stock News Bot	December 8, 2005 02:30:00 AM
NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Dec. 8, 2005--BrainStorm Cell Therapeutics (OTCBB:BCLI), the developer of NurOwn(TM) bone marrow derived stem cell therapeutic products for the... view message ignore post recommend post

#3: BCLI News BrainStorm Chief Scientist to Present at California-Israel Stem Cell Symposium
Stock News Bot	November 16, 2005 02:30:00 AM
NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Nov. 16, 2005--BrainStorm Cell Therapeutics (OTCBB:BCLI), today announced that the company's chief scientist, Dr. Daniel Offen, will make a... view message ignore post recommend post

#2: BCLI News BrainStorm Announces Significant Preclinical Benefit of Its GDNF Producing Stem Cells in Animal Models of Parkinson's
Stock News Bot	October 31, 2005 02:00:00 AM
NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Oct. 31, 2005--BrainStorm Cell Therapeutics (OTCBB:BCLI), today announced that the company's scientific collaborators at Tel Aviv University had... view message ignore post recommend post

#1: BCLI News Research BrainStorm Cell Therapeutics, Stock Trading Message Board
Stock News Bot	July 18, 2005 06:33:14 AM
BrainStorm Cell Therapeutics Announces Adult Stem Cell Breakthrough for Neurodegenerative Diseases; Differentiation into GDNF-Producing Astrocytes BrainStorm Cell Therapeutics (OTCBB:BCLI), today... view message ignore post recommend post

Group Home | Login if you want to post a message